Insider trading

Period: 120 months Stock: AMRN + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

98 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

98 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

98 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

98 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
98 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
98 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

98 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
22 Feb 2019
Kalb Michael Wayne SVP and CFO
Sold, plan not stated
$948.50K 50,000 at 18.97
70.9%
Sold half or more
15 Feb 2019
Kalb Michael Wayne SVP and CFO
Sold, plan not stated
$439.53K 25,000 at 17.58
54.9%
Sold half or more
1 Feb 2019
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$477.50K 27,989 at 17.06
7.3%
31 Jan 2019
Kennedy Joseph T General Counsel
Sold, plan not stated
$745.47K 42,624 at 17.49
57.7%
Sold half or more
31 Jan 2019
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$166.87K 9,541 at 17.49
2.7%
24 Jan 2019
Kennedy Joseph T General Counsel
Sold, plan not stated
$10.75M 609,115 at 17.66
100%
Sold half or more
23 Jan 2019
Kennedy Joseph T General Counsel
Sold, plan not stated
$4.59M 255,779 at 17.95
54.0%
Sold half or more
22 Jan 2019
Kennedy Joseph T General Counsel
Sold, plan not stated
$3.14M 175,300 at 17.92
44.6%
11 Jan 2019
Kennedy Joseph T General Counsel
Sold, plan not stated
$60.03K 3,173 at 18.92
1.4%
10 Jan 2019
Sold, plan not stated 2×
$3.40M 200,000 at 16.98
70.3%
Sold half or more
10 Jan 2019
Ekman Lars Director
Sold, plan not stated 5×
$2.43M 140,416 at 17.28
100%
Sold half or more
10 Jan 2019
STACK DAVID M Director · indirect
Sold, plan not stated
$1.77M 98,572 at 18.00
100%
Sold half or more
10 Jan 2019
STACK DAVID M Director
Sold, plan not stated
$484.78K 26,932 at 18.00
100%
Sold half or more
9 Jan 2019
Kalb Michael Wayne SVP and CFO
Sold, plan not stated
$3.05M 200,000 at 15.26
92.0%
Sold half or more
2 Jan 2019
Sold, plan not stated
$5.02M 385,000 at 13.03
82.0%
Sold half or more
31 Dec 2018
Kennedy Joseph T General Counsel
Sold, plan not stated
$363.55K 26,943 at 13.49
11.0%
31 Dec 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$230.21K 17,041 at 13.51
4.8%
28 Dec 2018
Sold, plan not stated
$1.87M 141,500 at 13.19
62.6%
Sold half or more
30 Nov 2018
Kennedy Joseph T General Counsel
Sold, plan not stated
$415.00K 23,306 at 17.81
9.7%
30 Nov 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$303.17K 17,042 at 17.79
4.8%
12 Nov 2018
THERO JOHN F President and CEO
Sold, plan not stated 4×
$11.59M 607,611 at 19.07
22.5%
31 Oct 2018
Kennedy Joseph T General Counsel
Sold, plan not stated 2×
$483.36K 23,307 at 20.74
9.7%
31 Oct 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated 2×
$353.45K 17,042 at 20.74
4.8%
1 Oct 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$2.01M 116,604 at 17.20
25.5%
1 Oct 2018
Kennedy Joseph T General Counsel
Sold, plan not stated 3×
$844.53K 50,249 at 16.81
18.7%
28 Sep 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated 2×
$3.10M 200,000 at 15.50
36.9%
25 Sep 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated 2×
$2.70M 200,000 at 13.50
36.9%
24 Sep 2018
Kennedy Joseph T General Counsel
Sold, plan not stated 3×
$11.40M 1,079,706 at 10.56
83.2%
Sold half or more
24 Sep 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated 3×
$7.06M 679,241 at 10.39
66.6%
Sold half or more
24 Sep 2018
Sold, plan not stated 3×
$5.30M 500,000 at 10.60
68.9%
Sold half or more
24 Sep 2018
Kalb Michael Wayne SVP and CFO
Sold, plan not stated 2×
$1.56M 150,000 at 10.42
90.9%
Sold half or more
2 Jul 2018
Kennedy Joseph T General Counsel
Sold, plan not stated
$80.96K 26,942 at 3.00
59.4%
Sold half or more
3 Apr 2018
Kennedy Joseph T General Counsel
Sold, plan not stated
$55.05K 19,042 at 2.89
50.8%
Sold half or more
2 Apr 2018
Kennedy Joseph T General Counsel
Sold, plan not stated
$23.02K 7,900 at 2.91
17.4%
31 Jan 2018
Kennedy Joseph T General Counsel
Sold, plan not stated
$167.39K 44,857 at 3.73
70.9%
Sold half or more
23 Jan 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$596.43K 135,205 at 4.41
48.8%
17 Jan 2018
Kennedy Joseph T General Counsel
Sold, plan not stated
$127.02K 31,519 at 4.03
100%
Sold half or more
16 Jan 2018
Kennedy Joseph T General Counsel
Sold, plan not stated
$41.30K 10,000 at 4.13
24.1%
12 Jan 2018
Kennedy Joseph T General Counsel
Sold, plan not stated
$41.13K 9,587 at 4.29
18.8%
11 Jan 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$11.49K 2,612 at 4.40
1.8%
5 Jan 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$284.63K 64,683 at 4.40
31.3%
2 Jan 2018
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$545.09K 128,257 at 4.25
47.5%
30 Nov 2017
THERO JOHN F President and CEO
Bought
$32.45K 10,000 at 3.24
0.9%
First buy on file
5 Oct 2017
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$221.20K 63,479 at 3.48
30.9%
3 Jul 2017
Kennedy Joseph T General Counsel
Sold, plan not stated
$209.16K 51,104 at 4.09
100%
Sold half or more
30 Jun 2017
Kennedy Joseph T General Counsel
Sold, plan not stated
$417.95K 105,039 at 3.98
67.3%
Sold half or more
29 Jun 2017
Kennedy Joseph T General Counsel
Sold, plan not stated
$603.82K 151,768 at 3.98
53.8%
Sold half or more
9 Nov 2016
Kennedy Joseph T General Counsel
Sold, plan not stated
$372.04K 122,358 at 3.04
43.0%
Showing 51–98 of 98. ← Newer Page 2 of 2